US Patent 7582775 Vitamin D receptor modulators
Patent 7582775 was granted and assigned to Eli Lilly and Company on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+284 characters)
Article
Patent abstract
The present invention relates to novel, non-secosteroidal, phenyl-benzothiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07582775 Vitamin D receptor modulators US Patent 7582775 Vitamin D receptor modulators
Infobox
Patent Number
0758277500
Patent Number
758277500
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075827750
Date of Patent
September 1, 2009
0Patent Application Number
105795640
Date Filed
November 16, 2004
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075827750
Date of Patent
September 1, 2009
0Patent Application Number
105795640
Date Filed
November 16, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07582775 Vitamin D receptor modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07582775
Date of patent
September 1, 2009
Patent application number
10579564
Date Filed
November 16, 2004
Patent primary examiner
Find more entities like US Patent 7582775 Vitamin D receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.